trihexyphenidyl has been researched along with Psychotic Disorders in 30 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma chlorpromazine (CPZ) levels of 50 psychotic inpatients were measured by gas liquid chromatography; the clinical progress of 29 of these patients with acute psychoses was also assessed." | 3.65 | Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. ( Lasagna, L; Nasrallah, H; Rivera-Calimlim, L; Strauss, J, 1976) |
| "Central pontine and extrapontine myelinolysis (CPEM) are rare conditions usually associated with rapid correction of hyponatremia." | 1.34 | Psychotic disorder in a patient with central and extrapontine myelinolysis. ( Krystal, A; Lim, L, 2007) |
| " In this study, 44 clinically stable schizophrenic inpatients were administered a battery of neuropsychological tests, and their performance was correlated with dosage of neuroleptic medication and benztropine." | 1.28 | Relationships between medication treatments and neuropsychological test performance in schizophrenia. ( Haas, GL; Hill, J; Keilp, JG; Sweeney, JA; Weiden, PJ, 1991) |
| "Development of neuroleptic malignant syndrome (NMS) following discontinuation of high-dose and high-potency neuroleptic agents is described." | 1.28 | Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. ( Hermesh, H; Munitz, H; Spivak, B; Tyano, S; Weizman, A; Wolovick, L, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (80.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Subramanyam, AA | 1 |
| Nachane, HB | 1 |
| Mahajan, NN | 1 |
| Shinde, S | 1 |
| D Mahale, S | 1 |
| Gajbhiye, RK | 1 |
| Tanaka, K | 1 |
| Wada, I | 1 |
| Okunomiya, T | 1 |
| Shima, A | 1 |
| Kambe, D | 1 |
| Shinde, A | 1 |
| Kageyama, T | 1 |
| Suenaga, T | 1 |
| MULLER, L | 1 |
| ANDERSSON, B | 1 |
| NAHUNEK, K | 3 |
| RYBAKOVA, V | 1 |
| STOJILJKOVIC, S | 1 |
| PURKOV, M | 1 |
| BARTOVA, D | 1 |
| GERSON, IM | 1 |
| CHAT, E | 1 |
| TWIGGER, NA | 1 |
| MILLER, WD | 1 |
| WRIGHT, WB | 1 |
| Lim, L | 1 |
| Krystal, A | 1 |
| Fouks, L | 1 |
| Périvier, E | 1 |
| Houssait, A | 1 |
| Lerno, M | 1 |
| Good, MI | 1 |
| Molho, ES | 1 |
| Factor, SA | 1 |
| Podskalny, GD | 1 |
| Brown, D | 1 |
| Rivera-Calimlim, L | 1 |
| Nasrallah, H | 1 |
| Strauss, J | 1 |
| Lasagna, L | 1 |
| Grunhaus, L | 1 |
| Sancovici, S | 1 |
| Rimon, R | 1 |
| Simeon, J | 3 |
| Itil, TM | 3 |
| Sweeney, JA | 1 |
| Keilp, JG | 1 |
| Haas, GL | 1 |
| Hill, J | 1 |
| Weiden, PJ | 1 |
| Spivak, B | 1 |
| Weizman, A | 1 |
| Wolovick, L | 1 |
| Hermesh, H | 1 |
| Tyano, S | 1 |
| Munitz, H | 1 |
| Vågen, R | 1 |
| Götestam, KG | 1 |
| Hardie, RJ | 1 |
| Lees, AJ | 1 |
| McInnis, M | 1 |
| Petursson, H | 1 |
| Saletu, B | 2 |
| Saletu, M | 2 |
| DaSilva, J | 2 |
| Turek, I | 1 |
| Kurland, AA | 1 |
| Hanlon, TE | 1 |
| Bohm, M | 1 |
| Orlov, P | 1 |
| Kasparian, G | 1 |
| DiMascio, A | 1 |
| Cole, JO | 1 |
| Naviau, J | 1 |
| Minns, RA | 1 |
| Maller, O | 1 |
| Heller, S | 1 |
| Meyer, HH | 1 |
5 trials available for trihexyphenidyl and Psychotic Disorders
| Article | Year |
|---|---|
An experimental evaluation of the euphoric properties of antiparkinson drugs on psychotic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Euphoria; Female; Humans; Male; | 1986 |
Withdrawal of trihexyphenidyl.
Topics: Adult; Anxiety; Basal Ganglia Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Psyc | 1985 |
Thiothixene in childhood psychoses.
Topics: Alpha Rhythm; Autistic Disorder; Body Weight; Child Behavior Disorders; Clinical Trials as Topic; Co | 1974 |
Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Electroencephalograp | 1974 |
Neutralization of extrapyramidal side-effects with Methixene.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Extrapyramidal Tracts; Female; Humans; Male; Middle Age | 1971 |
25 other studies available for trihexyphenidyl and Psychotic Disorders
| Article | Year |
|---|---|
Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India.
Topics: Antipsychotic Agents; Asymptomatic Infections; COVID-19; Delusions; Female; Hallucinations; Haloperi | 2020 |
Dropped head syndrome preceding the onset of dementia with Lewy bodies.
Topics: Aged; Brain; Cholinergic Antagonists; Female; Humans; Iofetamine; Lewy Body Disease; Magnetic Resona | 2014 |
[Mental disorders as complication of pargitan therapy of extrapyramidal symptoms].
Topics: Basal Ganglia Diseases; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorders; | 1953 |
[Parkinsonism-like symptoms caused by chlorpromazine therapy].
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Parkinson Disease; Parkinsonian Disorders; Psycho | 1958 |
[Severe mental disorders after the application of artane].
Topics: Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorders; Trihexyphenidyl | 1960 |
[The treatment of endogenous depression with perphenazine and trihexyphenidyl. Relation to extrapyramidal symptomatology].
Topics: Bipolar Disorder; Depression; Depressive Disorder; Extrapyramidal Tracts; Humans; Mental Disorders; | 1962 |
[ON THE USE OF A COMBINATION OF RESERPINE AND TRIHEXYLPHENIDYL IN ENDOGENOUS DEPRESSIVE STATES].
Topics: Bipolar Disorder; Depressive Disorder; Humans; Mental Disorders; Psychotic Disorders; Reserpine; Tri | 1963 |
CLINICAL TRIAL OF A POTENTIATED DIKETOPIPERAZINE DERIVATIVE AS A PSYCHOPHARMACOLOGICAL AGENT FOR THE TREATMENT OF PSYCHOTIC PATIENTS.
Topics: Biomedical Research; Catatonia; Depression; Depressive Disorder; Diketopiperazines; Humans; Leukopen | 1964 |
Toxic psychosis due to artane.
Topics: Humans; Mental Disorders; Psychotic Disorders; Trihexyphenidyl | 1951 |
Behaviour disorders associated with Artane treatment of post-encephalitic Parkinsonism.
Topics: Conduct Disorder; Humans; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; | 1952 |
Psychotic disorder in a patient with central and extrapontine myelinolysis.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Baclofen; Fema | 2007 |
[Indications and modes of administration of fluphenazine enanthate].
Topics: Fluphenazine; Humans; Injections; Orphenadrine; Parasympathomimetics; Psychotic Disorders; Trihexyph | 1967 |
Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Middle Ag | 1981 |
The effect of dancing on dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesi | 1996 |
Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Brief Psychiatric Rating Scale; Chlorproma | 1976 |
Neuroleptic malignant syndrome due to depot fluphenazine.
Topics: Adult; Coma; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Fever; Fluphenazine; Humans; Mal | 1979 |
Computerized Electroencephalogram. A model of understanding the brain function in childhood psychosis and its treatment.
Topics: Acoustic Stimulation; Adolescent; Autistic Disorder; Brain; Child; Child, Preschool; Diagnosis, Comp | 1975 |
Relationships between medication treatments and neuropsychological test performance in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benztropine; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 1991 |
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Co | 1990 |
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Drug Therapy, Combination; Female; Humans; Levodopa; | 1988 |
Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
Topics: Aged; Chronic Disease; Female; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorder | 1972 |
Withdrawal of antiparkinson drugs.
Topics: Biperiden; Butyrophenones; Female; Humans; Male; Parasympatholytics; Parkinson Disease; Psychotic Di | 1971 |
[On the use of sulpiride in psychiatric therapy].
Topics: Adolescent; Adult; Aged; Amitriptyline; Butyrophenones; Diazepam; Drug Synergism; Female; Humans; Ma | 1969 |
A case of Capgras' syndrome.
Topics: Adult; Chlorpromazine; Delusions; Female; Humans; Psychotic Disorders; Schizophrenia; Trifluoperazin | 1970 |
[On the question of possible irreversible disorders due to psychopharmacotherapy].
Topics: Adult; Autonomic Nervous System; Biperiden; Butyrophenones; Central Nervous System; Chlorpromazine; | 1966 |